Letter from Pr Henri Joyeux no 138
In his letter to all those affected by Alzheimer’s disease, Pr Henri Joyeux gets the father of the disease himself to talk. How did he discover and describe it? Why is it named after him? Why are all the treatments proposed to patients, even at the onset of the disease, completely ineffective? The recent controversy about reimbursements is significant: experts are asking to put a stop to the reimbursement of useless and costly drugs, and the French Minister of health wants to maintain them to avoid losing the votes of the elderly.
Alois Alzheimer presents the discovery made in France by Pr Jean-Bernard Fourtillan, a professor of medicinal chemistry. It relates to the regulation of the Sleep-Wake system, which is the responsibility of the pineal gland, aka epiphysis. The deregulation of this system causes all the disorders of the disease. Incredible therapeutic prospects for tens of millions of people worldwide.
Letter from Pr Henri Joyeux no 137
In this original letter, it is the pineal gland which is talking to you, informing you of its location, shape and dimensions. The most important thing is of course its role and the fundamental discovery that it is the source of Sleep-Wake regulation in human beings.
You will comprehend what the actual purpose of Melatonin is, while recognising the wake and cognition hormone and, more importantly, the sleep hormone, aka Valentonin. This discovery was obviously protected by patents, after which it was presented on 2 December 2015 to the National Pharmaceutical Academy, before an audience of scientists. This small pineal gland has fascinated for centuries. Outside the brain’s protective barrier known as the “blood-brain barrier”, the hormones it produces are distributed throughout the body according to its needs. This tiny gland is therefore the supreme conductor of hormonal symphonies.
This discovery has tremendous therapeutic implications which are currently being identified. It will be instrumental in preventing and overcoming neuro-degenerative diseases, particularly Alzheimer’s and Parkinson’s disease, as long as there are no definitive and irreversible lesions.